or
forgot password

    • cancer clinical trials in nashville, TN

    • Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Myelodysplastic Syndrome (MDS)
    Study of Ruxolitinib in Pancreatic Cancer Patients

    Nashville, Tennessee 37203-1632
    Metastatic Pancreatic Adenocarcinoma
    Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Melanoma, Malignant Melanoma
    A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
    Investigational Site Number 840002
    Nashville, Tennessee 37232
    Solid Tumor Cancers
    Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
    Site Reference ID/Investigator# 54142

    Trial Locations
    Site Reference ID/Investigator# 54142
    Site Reference ID/Investigator# 89653
    Heavy Uterine Bleeding, Uterine Fibroids
    Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
    Vanderbilt Ingram Cancer Center

    Trial Locations
    Vanderbilt Ingram Cancer Center
    Sarah Cannon Research Institute
    Small Cell Lung Carcinoma
    Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
    Vanderbuilt University
    Nashville, Tennessee 37232
    Acute Myeloblastic Leukemia
    Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Myelodysplastic Syndrome (MDS)
    A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    CD27 Expressing B-cell Malignancies, CD27 Expressing Solid Tumors, Chronic Lymphocytic Leukemia, Burkett's Lymphoma, Mantle Cell Lymphoma, Primary Lymphoma of the Central Nervous System, Marginal Zone B Cell Lymphoma, Solid Tumor, Metastatic Melanoma, Renal (Clear) Cell Carcinoma, Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer, Colorectal Adenocarcinoma, Non-small Cell Lung Cancer, Melanoma (Solid Tumor Expansion Arm Only)
    Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Carcinoma, Recurrent Islet Cell Carcinoma
    Nashville Early Diagnosis Lung Cancer Project
    Veterans Administration

    Trial Locations
    Veterans Administration
    Vanderbilt University, Vanderbilt-Ingram Cancer Center
    Meharry Medical Center
    Lung Cancer
    Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Glioma, Glioblastoma, Glioblastoma Multiforme, GBM, Brain Cancer
    A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
    Sarah Cannon Research - Drug Development Unit
    Nashville, Tennessee 37203
    Relapsed or Refractory Solid Tumors
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Nashville Breast Center
    Nashville, Tennessee 37203
    Breast Cancer
    Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): Pilot Study
    Vanderbilt Medical Center
    Nashville, Tennessee 37232-2765
    Infection, Bone Neoplasms
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Sarah Cannon Research Institute
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
    A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
    Vanderbilt Children's Hospital
    Nashville, Tennessee 37232-6310
    Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia
    Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Obesity, Overweight, Craniopharyngioma
    Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
    Urology Associates, P.C.
    Nashville, Tennessee 37209
    Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer
    Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Esophageal Cancer, Neoplasms, Esophageal
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Sarah Cannon Research Institute

    Trial Locations
    Sarah Cannon Research Institute
    Sarah Cannon Research Institute (SCRI)
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Prostate Cancer
    GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
    Tennessee Oncology
    Nashville, Tennessee 37203
    Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids
    Vanderbilt Medical Center
    Nashville, Tennessee 37232-2765
    Uterine Fibroids
    Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome
    A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

    Nashville, Tennessee 37203-1632
    Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer
    Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine
    Sarah Cannon Cancer Center
    Nashville, Tennessee 37203
    Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
    Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

    Nashville, Tennessee 37203-1632
    Prostate Cancer, Castration Resistant Prostate Cancer, Pain, Prostatic Neoplasms
    A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma

    Nashville, Tennessee 37203-1632
    Malignant Melanoma
    Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)
    Vanderbilt University Medical Center Vanderbilt Med Ctr
    Nashville, Tennessee 37232
    Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors
    A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers

    Nashville, Tennessee 37203-1632
    Multiple Myeloma, Neoplasms
    Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage I Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma, Stage IV Mantle Cell Lymphoma
    Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
    Tennessee Oncology
    Nashville, Tennessee 37203
    Locally Advanced HER2-Negative Breast Cancer
    Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Combined Type Small Cell Lung Cancer, Fusiform Type Small Cell Lung Cancer, Lymphocyte-like Type Small Cell Lung Cancer, Polygonal Type Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Lymphoma, Non-Hodgkin
    A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
    Sarah Cannon Cancer Center
    Nashville, Tennessee 37203
    Chronic Lymphocytic Leukemia